News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Erika Hamilton: Happy to join the panel of FDA-ASCO
Photo from Erika Hamilton/LinkedIn
Sep 4, 2024, 14:06

Erika Hamilton: Happy to join the panel of FDA-ASCO

Erika Hamilton, Breast Executive Committee Director at Sarah Cannon Research Institute, shared a post on LinkedIn:

“FDA-ASCO joint workshop on reproductive toxicity and how we should be better monitoring/measuring this in clinical trials.

Happy to join this panel. Open to the public.

Agenda and registration here.”

Erika Hamilton: Happy to join the panel of FDA-ASCO

Source: Erika Hamilton/LinkedIn

ASCO-FDA cancer Erika Hamilton OncoDaily Oncology reproductive toxicity Sarah Cannon Research
Special Coverage
Blog
Sep 4, 2024, 14:06
Erika Hamilton: Happy to join the panel of FDA-ASCO
Blog
Sep 4, 2024, 12:44
Lung Cancer Policy Network at WCLC
Blog
Sep 4, 2024, 12:38
ASCO endorsed CPOEM Foundation webinar on managing Head and Neck Cancers
Blog
Sep 4, 2024, 12:32
Avirup Guha: Our abstract at ESC Congress 2024 on Rurality and outcomes in prostate cancer
Blog
Sep 4, 2024, 11:56
Darcy Burbage: Let’s support families impacted by childhood cancer
Blog
Sep 4, 2024, 11:52
Frequently asked questions about biomarker testing in NSCLC - LUNGevity Foundation
Dialogues
Sep 4, 2024, 11:47
Dr. Benjamin Schlechter on Botensilimab: Practice-changing Drug | Most Promising Cancer Drugs 2024
Blog
Sep 4, 2024, 11:43
Rochelle G Prosser: I am excited to speak about Precision Oncology at the FNIH's Team Science Day
Insight
Sep 4, 2024, 11:31
Fabio Moraes: Thrilled to see Dr. Gouveia presenting two papers at WCLC24
Blog
Sep 4, 2024, 11:19
OncoInfluencers to Follow on Social Media: Dr. Rachel Riechelmann
Insight
Sep 4, 2024, 11:18
ESGO-ESHRE-ESGE guidelines for fertility-sparing treatment and follow-up in patients with cervical and ovarian cancer and borderline ovarian tumours
Insight
Sep 4, 2024, 10:54
Article of the day, September 4th, suggested by the Immune Oncology Research Institute